Phaos Technology Holdings (Cayman) (POAS) Operating Leases (2024 - 2025)

Phaos Technology Holdings (Cayman) (POAS) posted Operating Leases of $10257.0 for Q4 2025, down 39.61% on a QoQ basis from $16984.2 in Q2 2025.

Phaos Technology Holdings (Cayman) (POAS) Operating Leases (2024 - 2025) Analysis & Trends

Phaos Technology Holdings (Cayman)'s Operating Leases history runs 2 years deep, the most recent figure standing at $10257.0 for Q4 2025.

Quarterly Operating Leases changed N/A year-over-year to $10257.0 in Q4 2025, while the trailing twelve-month figure through Oct 2025 was $10257.0 (changed N/A YoY) and the FY2025 annual result came in at $16999.7, down 73.18% from the prior year.
Operating Leases was $10257.0 for Q4 2025 at Phaos Technology Holdings (Cayman), down from $16984.2 in the prior quarter.
Across five years, Operating Leases topped out at $63378.3 in Q2 2024 and bottomed at $10257.0 in Q4 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Abbott Laboratories	183.88 Bn	176.59 Bn	6.27 Bn
2	Stryker	128.95 Bn	126.07 Bn	3.81 Bn
3	Medtronic	108.68 Bn	99.46 Bn	6.41 Bn
4	Boston Scientific	68.54 Bn	67.09 Bn	3.61 Bn
5	Edwards Lifesciences	48.26 Bn	44.58 Bn	1.29 Bn
6	Dexcom	28.39 Bn	27.28 Bn	750.30 Mn
7	GE HealthCare Technologies	28.22 Bn	25.93 Bn	1.98 Bn
8	Smith & Nephew	26.89 Bn	26.31 Bn	-
9	Koninklijke Philips	24.66 Bn	21.54 Bn	2.07 Bn
10	Phaos Technology Holdings (Cayman)	6.24 Mn	6.18 Mn	-

Download Data